These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7817337)

  • 1. [Study of hepatic drug metabolism. For a rationalization of a new molecular development].
    Le Dinh T; Christoforov B
    Therapie; 1994; 49(2):133-40. PubMed ID: 7817337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What do we know about the drug metabolism?].
    Pelkonen O; Raunio H
    Duodecim; 1998; 114(10):971-7. PubMed ID: 11524785
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolism and drug interactions in the elderly.
    Herrlinger C; Klotz U
    Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):897-918. PubMed ID: 11866484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of drug metabolites with hepatic cytochrome P-450. Some implications for drug metabolism.
    Bast A
    Pharm Weekbl Sci; 1982 Aug; 4(4):113-4. PubMed ID: 7133961
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of drug metabolism and interactions on the basis of in vitro investigations.
    Pelkonen O; Turpeinen M; Uusitalo J; Rautio A; Raunio H
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):167-75. PubMed ID: 15733211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?
    Tang C; Lin JH; Lu AY
    Drug Metab Dispos; 2005 May; 33(5):603-13. PubMed ID: 15673596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic control of drug oxidation in the liver.
    Dayer P; Balant L; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):421-5. PubMed ID: 6147316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of drugs. III. Genetic factors inducing and inhibiting metabolism].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):457-61. PubMed ID: 16161934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interindividual variability in drug metabolism, especially in the elderly. Underlying mechanisms and a possible solution].
    van Bezooijen CF
    Tijdschr Gerontol Geriatr; 1988 Apr; 19(2):61-4. PubMed ID: 3376191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.
    Touw DJ
    Drug Metabol Drug Interact; 1997; 14(2):55-82. PubMed ID: 9893738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods for studying the hepatic metabolism of drugs in man].
    Geneve J; Bergmann JF; Caulin C; Segrestaa JM
    Therapie; 1990; 45(2):91-7. PubMed ID: 2191470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions evaluation: an integrated part of risk assessment of therapeutics.
    Zhang L; Reynolds KS; Zhao P; Huang SM
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):134-45. PubMed ID: 20045016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of drug interaction studies in drug development: the good, the bad, and the unknown.
    Alfaro CL
    Psychopharmacol Bull; 2001; 35(4):80-93. PubMed ID: 12397858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety.
    Lu AY
    Drug Metab Dispos; 1998 Dec; 26(12):1217-22. PubMed ID: 9860931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.